EA
Emerald Advisers’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-456,202
| Closed | -$15.5M | – | 259 |
|
|
2024
Q3 | $15.5M | Buy |
456,202
+257,773
| +130% | +$8.76M | 0.6% | 68 |
|
|
2024
Q2 | $7.34M | Sell |
198,429
-13,606
| -6% | -$504K | 0.31% | 102 |
|
|
2024
Q1 | $8.9M | Buy |
+212,035
| New | +$8.9M | 0.36% | 100 |
|
|
2013
Q4 | – | Sell |
-455,619
| Closed | -$16.1M | – | 353 |
|
|
2013
Q3 | $16.1M | Buy |
455,619
+36,954
| +9% | +$1.31M | 0.91% | 25 |
|
|
2013
Q2 | $6.54M | Buy |
+418,665
| New | +$6.54M | 0.4% | 83 |
|